T-DXD Plus Pertuzumab Improves QOL, Safety in HER2+ Breast CancerByPaige BrittJanuary 8th 2026Destiny-Breast09 PROs demonstrated higher quality of life and fewer gastrointestinal symptoms in patients with HER2-positive advanced breast cancer.
HRT Not Linked to Increased Risk of BRCA1/2+ Breast CancerByPaige BrittDecember 17th 2025Hormone replacement therapy was associated with a lower risk of developing BRCA1- or BRCA2-mutated breast cancer among those already at higher risk.